| Literature DB >> 27799300 |
Catherine H Freudenreich, Xiaofeng A Su.
Abstract
Early screens in yeast for mutations exhibiting sensitivity to DNA damage identified nuclear pore components, but their role in DNA repair was not well understood. Over the last decade, studies have revealed that several types of persistent DNA lesions relocate to either the nuclear pore complex (NPC) or nuclear envelope (NE). Of these two sites, the nuclear pore appears to be crucial for DNA repair of persistent double-strand breaks, eroded telomeres and sites of fork collapse at expanded CAG repeats. Using a combination of cell biological imaging techniques and yeast genetic assays for DNA repair, researchers have begun to understand both the how and why of lesion relocation to the NPC. Here we review the types of lesions that relocate to the NPC, mediators of relocation and the functional consequences of relocation understood to date. The emerging theme is that relocation to the NPC regulates recombination to influence repair pathway choice and provide a rescue mechanism for lesions or DNA structures that are resistant to repair. © FEMS 2016.Entities:
Keywords: DNA repair; collapsed replication fork; eroded telomere; nuclear pore complex; persistent DSB; recombination
Mesh:
Substances:
Year: 2016 PMID: 27799300 PMCID: PMC5113167 DOI: 10.1093/femsyr/fow095
Source DB: PubMed Journal: FEMS Yeast Res ISSN: 1567-1356 Impact factor: 2.796
Figure 1.Saccharomyces cerevisiae NPC structure. The diagram is drawn based on Schwartz (2016); the composite high-resolution Y-shape complex structure is from Kelley et al. (2015). FG-nups are nucleoporins containing repetitive phenylalanine (F) and glycine (G) amino acid sequences.
Interactions at the NPC and functional consequences.
| Lesion type | NPC component associated with lesion | Cell cycle phase of association | Mediators (NPC interaction dependent on) | Function of relocalization | Reference |
|---|---|---|---|---|---|
| Persistent DSB (HO | Nup84 (ChIP) | G1/S/G2 | Slx5/8 | Increase survival | Nagai |
| break, no donor for | Nup133 (ChIP) | Mec1/Tel1 | Promote gene conversion | Kalocsay, Hiller and | |
| repair) | Nic96 (ChIP) | Swr1 | Promote ectopic BIR | Jentsch ( | |
| Nup49 (Imaginga, b) | Mms21 | Promote MMEJ |
| ||
| Siz2 | Suppress GCRs |
| |||
| Smc5/6e | |||||
| Subtelomeric DSB | Nup84 (ChIP) | N/D | Kinesin14 (Cik1, Kar3) | Increase survival | Therizols |
| Cohibin (Lrs4, Csm1) | Promote end joiningf | Chung | |||
| Swr1e | Promote Rad52-dependent BIR | ||||
| Eroded telomere | Nup49 (ChIP, | Senescing | Slx5/8 | Relocalize to pores from NE | Khadaroo |
| (Imaginga) | cells | Siz1/Siz2 | Promote Rad52-dependent | Churikov | |
| Rad9/Rad24e | type II recombination | ||||
| Collapsed fork | Nup49 (Imaginga, b) | S | - | Increase survival | Nagai |
| by HU + MMSc | Promote fork restart | ||||
| Collapsed fork at | Nup49 (Imagingb) | S | Nup84 | Reduce repeat breakage and | Su |
| CAG repeatsd | Nup84 (ChIP) | Slx5/8 | instability | ||
| Suppress Rad52-dependent HR |
Colocalization of fluorescently tagged pore protein with the lesion in either wild-type or nup133ΔN mutant cells (which clusters NPCs to one side of the nucleus; Doye, Wepf and Hurt 1994).
Preferential localization of the lesion at the periphery of the nucleus (zone 1) by zoning analysis.
Induced collapsed fork by treatment with 0.2 M HU and 0.03% MMS.
(CAG)70 or (CAG)130 repeat tracts.
Mutant causes partial delocalization.
Concluded to be NHEJ in Therizols et al. (2006), but a significant fraction (at least 40%) had what is now accepted as a MMEJ signature.
Interactions at the NE and functional consequences.
| Lesion type | NE component associated with lesion | Cell cycle phase of association | Mediators (NE interaction dependent on) | Function of tethering | Reference |
|---|---|---|---|---|---|
| Persistent DSB (HO break, no donor for repair) | Mps3 (ChIP, Imaginga) Heh2 (ChIP) | S/G2 | Rad51, Rad52, Rad9/Rad24, H2A.Zc, Swr1, INO80 (Arp8) SMC5/6 (Nse5), Mms21, Rtt107 | Delays HR repair Repress uSCR Repress HR with an ectopic donor Promote GCRs in NP mutants Recruit telomerase | Kalocsay, Hiller and Jentsch ( |
| Cdc13 | |||||
| Slowly repaired DSB (30 kb resection required for SSA) | Mps3 (ChIP) | N/D | N/D | Unclear (repair is dependent on Rad52, partially on Nup84) | Oza |
| Repairable DSB (HO break, ectopic donor on different chromosome) | Mps3 (ChIPb, Imaginga) | N/D | N/D | Suppress HR with an ectopic donor | Oza |
Preferential localization of the lesion at the periphery of the nucleus (zone 1) is lost in the mps3ΔN mutant.
Repairable DSBs do not show a zone 1 increase by imaging or bind to Mps3 by ChIP (Nagai et al.2008; Oza et al.2009).
H2A.Z is encoded by the HTZ1 gene; NE interaction is also lost in htz1-K126R, K133R non-sumoylatable mutants (Kalocsay, Hiller and Jentsch 2009) or the htz1ΔM6 mutant that doesn't bind SWR-C, but retains its Mps3 inner nuclear membrane localization function (Gardner et al.2011; Horigome et al.2014).
Figure 2.Summary of lesions found to relocate to the nuclear pore, some sumoylated proteins expected to bind them and observed functional outcomes of relocation. At top is a model for the function of relocation of persistent DNA lesions to the nuclear pore. The dashed line between Slx5/Slx8 STUbL and the Y-shaped Nup84 complex indicates interaction between Nup84 and Slx8 shown by Nagai et al. (2008). The isopeptidase Ulp1 that can cleave SUMO from modified proteins interacts with the nuclear basket. Three types of persistent DNA lesions that have been studied are illustrated at left. Only a few key proteins are shown; other proteins that have been shown to interact with these lesions and/or play a role in mediating interaction with the nuclear pore or NE are listed in Tables 1 and 2. The small blue circles represent SUMO (either mono-SUMO or poly-SUMO chains). TBP stands for telomere binding proteins. On the right are listed the known outcomes of interaction with the nuclear pore for each type of lesion (black arrows), or alternative outcomes that occur when NPC interaction is defective (gray arrows).